News

Benefits for patients, health care providers and manufacturers.

Big data has immense, yet so far hardly utilised potential to ...
WP7
April 28, 2017

Use of Real-World Data in Health Technology Assessment? Read the comparative Study on policies of Six HTA Agencies.

Randomised controlled trials provide robust data on
WP7
April 28, 2017

Actively involve all the relevant representatives of the Healtcare System.

Innovative therapies will be developed and provided in
WP7
April 28, 2017

Identifying opportunities for ‘big data’ in medicines development and regulatory science.

The HARMONY Alliance will provide the most comprehensive
WP7
April 16, 2017

PRESS RELEASE | HARMONY: Better care of patients with hematologic ...
WP7
January 19, 2017

PRESS RELEASE | Innovative Medicines Initiative approves € ...
WP7
January 09, 2017

EHA Newsletters and Journal HemaSphere including HARMONY articles ...
January 02, 2017

HARMONY communications working docs
January 01, 2017

1-24 25-48 49-72 73-96 97-120 121-144 145-168

HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology

Funded through the Innovative Medicines Initiative (IMI) 2 Joint Undertaking and listed under grant agreement No. 116026. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

HARMONY Coordination Office
Institute of Biomedical Research of Salamanca (IBSAL)
Salamanca, Spain

HARMONY Communications
European Hematology Association (EHA)
The Hague
The Netherlands